Hydronephrosis Market Report 2026

Hydronephrosis Market Report 2026
Global Outlook – By Type (Unilateral Hydronephrosis, Bilateral Hydronephrosis), By Indication (Intrinsic, Extrinsic), By Diagnosis (Laboratory Test, Imaging), By Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Other Treatments) - Market Size, Trends, And Global Forecast 2026-2035
Hydronephrosis Market Overview
• Hydronephrosis market size has reached to $3.38 billion in 2025 • Expected to grow to $5.48 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: The Growing Burden Of Kidney Diseases Fuels Hydronephrosis Market Expansion • Market Trend: Advancements In Hydronephrosis Treatment Enhanced Patient Care • North America was the largest region in 2025.What Is Covered Under Hydronephrosis Market?
Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to a buildup of urine. This occurs when the flow of urine is obstructed, causing the kidneys to become enlarged. It can result from blockages such as kidney stones, tumors, or anatomic abnormalities, and may lead to kidney damage if left untreated. The main types of hydronephrosis are unilateral hydronephrosis and bilateral hydronephrosis. Unilateral hydronephrosis is a condition where one kidney becomes swollen due to a buildup of urine caused by an obstruction or other issues in the urinary tract on that side. It is classified by its indication as either intrinsic or extrinsic. Diagnostics is primarily achieved through laboratory tests and imaging. Treatment options include shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.
What Is The Hydronephrosis Market Size and Share 2026?
The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.38 billion in 2025 to $3.74 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to improvements in diagnostic imaging technologies, rising incidence of kidney stones, increased awareness of renal disorders, expansion of hospital infrastructure, availability of surgical intervention options.What Is The Hydronephrosis Market Growth Forecast?
The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $5.48 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing aging population, rising prevalence of chronic kidney diseases, growing adoption of precision medicine approaches, expansion of advanced urology treatment centers, increased focus on early-stage diagnosis. Major trends in the forecast period include increasing use of advanced imaging diagnostics, rising adoption of minimally invasive treatment techniques, growing focus on early disease detection, expansion of integrated diagnostic and treatment pathways, enhanced monitoring of renal function.Global Hydronephrosis Market Segmentation
1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis 2) By Indication: Intrinsic, Extrinsic 3) By Diagnosis: Laboratory Test, Imaging 4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Other Treatments Subsegments: 1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis 2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral HydronephrosisWhat Is The Driver Of The Hydronephrosis Market?
The rising prevalence of kidney diseases is expected to propel the growth of the hydronephrosis market going forward. Kidney disease, also known as renal disease or nephropathy, refers to a range of conditions that result in damage to the kidneys, impairing their ability to filter blood effectively. The increasing cases of kidney diseases are due to several factors, such as the rising incidence of diabetes and hypertension, obesity, the aging population, and genetic and ethnic factors. Hydronephrosis is treated by addressing the underlying cause of the urinary obstruction, which may involve medications, surgery, or other interventions to restore normal urine flow. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, currently, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of kidney diseases is driving the growth of the hydronephrosis industry.Key Players In The Global Hydronephrosis Market
Major companies operating in the hydronephrosis market are Boston Scientific Corporation, Medtronic PLC, Cook Medical, Coloplast A/S, B. Braun Group, KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Teleflex Incorporated, BD, Terumo Corporation, UroGen Pharma Ltd., Urologix Inc., C. R. Bard, ConvaTec Group PLC, AngioDynamics Inc., Merit Medical Systems Inc., NxStage Medical Inc., Fresenius Medical Care, Nipro CorporationGlobal Hydronephrosis Market Trends and Insights
Major companies operating in the hydronephrosis market are developing innovative products such as drainage catheters to enhance patient care by providing efficient and minimally invasive solutions for draining urine from the kidneys. Drainage catheters are medical devices used to remove fluids, such as urine or blood, from the body to relieve pressure or prevent fluid accumulation. For instance, in October 2024, Argon Medical Devices Inc. is a US-based manufacturer of specialty medical products, launched the SKATER mini-loop drainage catheter. This catheter is a medical device designed for the minimally invasive drainage of unwanted fluid collections in the body. It is inserted through the skin using imaging guidance and features a loop that is 40% smaller, ensuring secure placement and effective drainage from smaller cavities. Known for its durability, kink resistance, and compatibility with alcohol, this catheter enhances usability in interventional procedures. By expanding Argon's drainage portfolio, the SKATER Mini-Loop aims to improve patient outcomes and streamline the drainage process for healthcare professionals.What Are Latest Mergers And Acquisitions In The Hydronephrosis Market?
In October 2023, Laborie Medical Technologies Corp., a US-based diagnostic company, acquired Urotronic Inc. for an undisclosed amount. The acquisition enhances Laborie's urology portfolio by offering proven, innovative solutions to physicians and patients worldwide. It enables Laborie to advance cutting-edge technologies to address unmet medical needs and deliver solutions that preserve and restore human dignity. Urotronic Inc. is a US-based medical device company that specializes in developing innovative treatments for urological conditions.Regional Outlook
North America was the largest region in the hydronephrosis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Hydronephrosis Market?
The hydronephrosis market includes revenues earned by entities by providing services such as urine flow monitoring, follow-up care, and minimally invasive procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Hydronephrosis Market Report 2026?
The hydronephrosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hydronephrosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Hydronephrosis Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.74 billion |
| Revenue Forecast In 2035 | $5.48 billion |
| Growth Rate | CAGR of 10.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Indication, Diagnosis, Treatment |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Boston Scientific Corporation, Medtronic PLC, Cook Medical, Coloplast A/S, B. Braun Group, KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Teleflex Incorporated, BD, Terumo Corporation, UroGen Pharma Ltd., Urologix Inc., C. R. Bard, ConvaTec Group PLC, AngioDynamics Inc., Merit Medical Systems Inc., NxStage Medical Inc., Fresenius Medical Care, Nipro Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Hydronephrosis market was valued at $3.38 billion in 2025, increased to $3.74 billion in 2026, and is projected to reach $5.48 billion by 2030.
The global Hydronephrosis market is expected to grow at a CAGR of 10.1% from 2026 to 2035 to reach $5.48 billion by 2035.
Some Key Players in the Hydronephrosis market Include, Boston Scientific Corporation, Medtronic PLC, Cook Medical, Coloplast A/S, B. Braun Group, KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Teleflex Incorporated, BD, Terumo Corporation, UroGen Pharma Ltd., Urologix Inc., C. R. Bard, ConvaTec Group PLC, AngioDynamics Inc., Merit Medical Systems Inc., NxStage Medical Inc., Fresenius Medical Care, Nipro Corporation .
Major trend in this market includes: Advancements In Hydronephrosis Treatment Enhanced Patient Care. For further insights on this market.
Request for SampleNorth America was the largest region in the hydronephrosis market in 2025. The regions covered in the hydronephrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
